Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Research Award: Canada Graduate Scholarships

University of Calgary

$120,000.00

Investigating the consequences of E. coli-LF82 invoked mitochondrial damage on IBD pathogenesis

FY 2024-25

Summary
Inflammatory bowel disease (IBD) is a group of diseases where the immune system attacks the digestive system, which over 450,000 Canadians will suffer from by 2030. Currently, there is no cure for IBD and the best treatments fail at some point in approximately 50% of patients, illustrating a need for new treatment targets. Mitochondria, the energy-generating organelles of the cell, are damaged in some IBD patients but the root causes of damage are unknown. Moreover, research in other inflammatory disorders has shown that damage to the mitochondria can release inflammatory molecules such as the mitochondria's DNA (mtDNA). Linking IBD and mitochondrial dysfunction, work from our group has shown that a specific strain of bacteria (AIEC-LF82) which is increased in IBD patients, damages the mitochondria. Furthermore, based on our preliminary data, this increase in bacteria causes escape of mtDNA into the cell's cytoplasm. This mtDNA, once in the cell's cytoplasm, can activate inflammatory pathways. These observations suggest a link between dysfunction of the mitochondria and the immune processes underlying IBD. Thus, I propose to investigate how mitochondrial DNA dysregulates inflammatory signalling in AIEC-LF82 infection to understand how IBD develops. I will examine what inflammatory mediators are released by AIEC-LF82 infection, how mtDNA escape occurs, and whether DNA-mediated inflammation and AIEC-LF82 infection affects barrier function of the colon. These experiments will focus on the epithelial cell, which forms the innermost lining of the gut and is the first line against invading species. Together these experiments will inform how AIEC-LF82 influences inflammatory signalling, how mitochondrial DNA escapes during the infection, what pathways are able to be targeted by treatments, and how inflammatory signalling changes the barrier function of the colon. As a result, this project could yield valuable insights to begin development of novel treatment targets.
Program
Doctoral Research Award: Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
518106
Name
Mohan Armaan
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Doctoral Research Awards - A
Projecttitle
Investigating the consequences of E. coli-LF82 invoked mitochondrial damage on IBD pathogenesis
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$120,000
Cihrequipment2
$0
Programname2
Doctoral Research Award: Canada Graduate Scholarships
Keyworddelim
Ibd; Inflammation; Mitochondria; Mitochondrial Dna
Abstract
Inflammatory bowel disease (IBD) is a group of diseases where the immune system attacks the digestive system, which over 450,000 Canadians will suffer from by 2030. Currently, there is no cure for IBD and the best treatments fail at some point in approximately 50% of patients, illustrating a need for new treatment targets. Mitochondria, the energy-generating organelles of the cell, are damaged in some IBD patients but the root causes of damage are unknown. Moreover, research in other inflammatory disorders has shown that damage to the mitochondria can release inflammatory molecules such as the mitochondria's DNA (mtDNA). Linking IBD and mitochondrial dysfunction, work from our group has shown that a specific strain of bacteria (AIEC-LF82) which is increased in IBD patients, damages the mitochondria. Furthermore, based on our preliminary data, this increase in bacteria causes escape of mtDNA into the cell's cytoplasm. This mtDNA, once in the cell's cytoplasm, can activate inflammatory pathways. These observations suggest a link between dysfunction of the mitochondria and the immune processes underlying IBD. Thus, I propose to investigate how mitochondrial DNA dysregulates inflammatory signalling in AIEC-LF82 infection to understand how IBD develops. I will examine what inflammatory mediators are released by AIEC-LF82 infection, how mtDNA escape occurs, and whether DNA-mediated inflammation and AIEC-LF82 infection affects barrier function of the colon. These experiments will focus on the epithelial cell, which forms the innermost lining of the gut and is the first line against invading species. Together these experiments will inform how AIEC-LF82 influences inflammatory signalling, how mitochondrial DNA escapes during the infection, what pathways are able to be targeted by treatments, and how inflammatory signalling changes the barrier function of the colon. As a result, this project could yield valuable insights to begin development of novel treatment targets.
Competitiondate
202411
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Mohan, Armaan
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $120,000~ $0~